FTC:WATCH No. 685 (2006-18)

Generic prescription drug competition enforcement increases...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

Try FTCWatch FREE for 45 days

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch

Current Issue: 1042
Next Issue: Feb 14, 2023

Browse Archives

In this Issue:

DOJ’s Google suit offers second shot at tech giant’s ad empire as Texas fights separate battle
A look at options for taming Ticketmaster’s monopoly
Neil Averitt commentary: Chess cheating, defamation and the Twombly pleading standard
Calendar
US merger probes fell in 2022, but 60 percent resulted in litigation or abandonment, report says
Petition pushes for online ad changes
ESG practices draw congressional scrutiny
FTC marks Identity Theft Awareness Week
Construction company owner sentenced for fraud scheme
People
Congresswoman Foxx tries to ban unwanted political calls
On the Shelf: Buck makes the conservative case for antitrust reform
Non-compete rulemaking faces legal hurdles but could help Biden politically
Privacy Corner: Qureshi seeks to hold tech giants accountable
2023 means uphill climb for FTC
Lawmakers increase FTC coffers, workload
Shifted US antitrust landscape likely to bring more litigation in 2023
Calendar
FTC eyes bots and fake accounts on social media
Successful Robinson-Patman revival must overcome dearth of expertise, rudderless private plaintiff bar

RSS Feed